Prosecution Insights
Last updated: October 25, 2026
Application No. 18/730,473

PROJECTION WRITING AND ERASING FILM AND PREPARATION METHOD AND USE THEREOF

Non-Final OA §102§103§112
Filed
Jul 19, 2024
Priority
Jul 12, 2023 — CN 202310857446.5 +3 more
Examiner
FIGG, TRAVIS M
Art Unit
1783
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Guangzhou Newlife New Material Co. Ltd.
OA Round
1 (Non-Final)
61%
Grant Probability
Moderate
1-2
OA Rounds
9m
Est. Remaining
79%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
262 granted / 427 resolved
-3.6% vs TC avg
Strong +17% interview lift
Without
With
+17.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
38 currently pending
Career history
456
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
62.0%
+22.0% vs TC avg
§102
11.6%
-28.4% vs TC avg
§112
21.2%
-18.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 427 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Claims Claims 1-20 are currently pending. Claims 8-17 are withdrawn from consideration. Election/Restrictions Applicant’s election without traverse of Group 1, claims 1-7 and 18-20, in the reply filed on 06/08/2026 is acknowledged. Claims 8-17 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 06/08/2026. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 3-6 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claims 3 and 6, The term “soft” in the phrase “soft film” is a relative term which renders the claim indefinite. The term “soft” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. It is unclear what is required for a film to be considered “soft”. For examination purposes, a “soft” film will be considered any film that is capable of having a surface or the film structure to be shaped or changed. Regarding claims 4 and 5, Claims 4 and 5 are rejected due to their dependency on claim 3. Additionally, claims 4 and 5 are indefinite for the phrase “acrylate-type” monomers. The addition of the word “type” extends the scope of the claims so as to render them indefinite since it is unclear what “type” is intended to convey. The addition of the word “type” to the otherwise definite expression renders the definite expression indefinite by extending its scope. Ex parte Copenhaver, 109 USPQ 118 (Bd. App. 1955). See MPEP 2173.05(b) II E. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 3, 6-7, and 20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Shimada et al. (JP 2010/046961 A; machine translation). Regarding claim 1, Shimada teaches a projecting writing and erasing film (Shimada: abstract; par. 0002, 0005, 0007, and 0010), comprising a surface clear layer having a structured surface (a surface structured layer) with a glossiness being suppressed and said structure layer may be a coating (a matte coating), a film base material layer, and an adhesive layer (an installation layer) (Shimada: abstract; par. 0006-0009 and 0023). Regarding claim 3, Shimada teaches the projection writing and erasing film required by claim 1. Shimada further teaches the surface structured layer is a curable coating and is shaped to have a thickness and uneven surface shapes on the surface (Shimada: par. 0023-0028). The limitations requiring the structured layer to be “formed by compounding a projection writing and erasing curable coating and a soft film with a roughened surface structure, curing and shaping, and then separating the projection writing and erasing curable coating from the soft film” are product-by-process limitations and are thus not given patentable weight. When the prior art discloses a product which reasonably appears to be either identical with or only slightly different than a product claimed in a product-by-process claim, a rejection based alternatively on either Section 102 or Section 103 is proper. See MPEP 2113. In th is case, there appears to be no structural difference between the final structure of the claimed projection writing and erasing film comprising a surface structured layer and the projection writing and erasing film comprising a surface structured layer coating taught by Shimada. Regarding claim 6, Shimada teaches the projection writing and erasing film required by claim 3. The limitations requiring the soft film with a roughened surface structure to comprise at least one polymer composition is also part of the product by process limitations required by claim 3. When the prior art discloses a product which reasonably appears to be either identical with or only slightly different than a product claimed in a product-by-process claim, a rejection based alternatively on either Section 102 or Section 103 is proper. See MPEP 2113. In th is case, there appears to be no structural difference between the final structure of the claimed projection writing and erasing film comprising a surface structured layer and the projection writing and erasing film comprising a surface structured layer coating taught by Shimada. Regarding claim 7, Shimada teaches the projection writing and erasing film required by claim 1. Shimada further teaches the base film layer (the base material layer) comprises a polyethylene terephthalate film, a polyvinyl chloride film, or an acrylic-based film (Shimada: par. 0031). Regarding claim 20, Shimada teaches the projection writing and erasing film required by claim 1. Shimada further teaches the surface structured layer has a thickens of from about 2 to about 6 µm, which is within the claimed range of 1 to 20 µm (Shimada: par. 0030). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 2 and 18-19 are rejected under 35 U.S.C. 103 as being unpatentable over Shimada. Regarding claim 2, Shimada teaches the projection writing and erasing film required by claim 1. Shimada further teaches the surface structure layer may have a 60-degree specular gloss of less than or equal to 30% or less which would overlap with the claimed range when converted to surface gloss claimed range of less than or equal to 30° (Shimada: par. 0023). A prima facie case of obviousness exists where the claimed ranges and prior art ranges overlap or are close enough that one skilled in the art would have expected them to have the same properties. See MPEP 2144.05 I. Regarding claim 18, Shimada teaches the projection writing and erasing film required by claim 1. Shimada further teaches the surface structured layer has an Ra of from about 1 to about 5 µm, which overlaps with the claimed 0.10 to 1.0 µm (Shimada: par. 0025). A prima facie case of obviousness exists where the claimed ranges and prior art ranges overlap or are close enough that one skilled in the art would have expected them to have the same properties. See MPEP 2144.05 I. Regarding claim 19, Shimada teaches the projection writing and erasing film required by claim 1. Shimada further teaches the surface structured layer has an Rt of about 1 to about 30 µm, which overlaps with the claimed 1.0 to 5 µm (Shimada: par. 0025). A prima facie case of obviousness exists where the claimed ranges and prior art ranges overlap or are close enough that one skilled in the art would have expected them to have the same properties. See MPEP 2144.05 I. Claims 4 and 5 are rejected under 35 U.S.C. 103 as being unpatentable over Shimada in view of Chen et al. (CN 112876980 A; machine translation). Regarding claims 4 and 5, Shimada teaches the projection writing and erasing film required by claim 3. Shimada further teaches the projection writing and erasing curable coating comprises the following preparation components: a base material comprising acrylate prepolymers and acrylate monomers and a photoinitiator (Shimada: par. 0009-0012). Shimada does not explicitly teach the addition of an antibacterial agent and a writing and erasing aid that is a fluorosilicone co-modified polyacrylate resin formed by the claimed components in the claimed proportions. Chen teaches an antibacterial ultraviolet curing writing coating composition with antibacterial properties and improved curing properties to obtain a good writing effect (Chen: abstract; pgs. 1-2, and pg. 3, par. 1). The coating composition comprises: 25 to 55 parts of acrylate resin prepolymer, which matches the range in the claims; 12 to 48 of an acrylic ester monomer (an acrylate-type monomer), matches the range for the acrylate-type monomers in the claim; 2.5 to 8 parts of a photoinitiator, which overlaps with claimed 1 to 4 parts; 1 to 8 parts of an antibacterial agent, which matches the claimed range; 1 to 5 parts of an erasing auxiliary agent (an erasing aid), which matches the claimed range (Chen: pg. 3, par. 6). The erasing aid comprises the following preparation components in parts by mass: 8 to 12 parts of hydrogen-containing silicon oil; 3 to 8 parts of silane monomer; 20 to 55 parts of double-functional (methyl)acrylate monomer; 1 to 3 parts of fluorine-containing (meth)acrylate monomer; 7x10-4 to 1.5x10-3 parts of a catalyst; and 0.3 to 0.6 parts of a polymerization inhibitor all of which matches the claimed ranges (Chen: pg. 4, par. 2). A prima facie case of obviousness exists where the claimed ranges and prior art ranges overlap or are close enough that one skilled in the art would have expected them to have the same properties. See MPEP 2144.05 I. Shimada and Chen are in the corresponding field of writing coating compositions. Therefore, it would be obvious to one of ordinary skill in the art to utilize the writing coating composition components in the claimed ranges of Chen in the curable coating of Shimada to provide improved writing, curing, and antibacterial properties as taught by Chen. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Travis M Figg whose telephone number is (571)272-9849. The examiner can normally be reached M-F 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Maria Veronica D. Ewald can be reached at 571-272-8519. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /TRAVIS M FIGG/Primary Examiner, Art Unit 1783
Read full office action

Prosecution Timeline

Jul 19, 2024
Application Filed
Aug 12, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12767858
MULTILAYER SHEET AND PRODUCTION METHOD THEREOF
2y 10m to grant Granted Oct 20, 2026
Patent 12753316
FILM AND METHOD OF PRODUCING THE SAME
3y 9m to grant Granted Oct 06, 2026
Patent 12754358
OPTICAL COMPENSATION FILMS BASED ON COMBINATIONS OF NEGATIVE BIREFRIGENT AND POSITIVE BIREFRIGENT COMPONENTS
3y 8m to grant Granted Oct 06, 2026
Patent 12736275
VACUUM ADIABATIC BODY AND REFRIGERATOR
3y 4m to grant Granted Sep 15, 2026
Patent 12715967
Fluororesin Film
3y 0m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
61%
Grant Probability
79%
With Interview (+17.2%)
3y 0m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 427 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month